Trials / Completed
CompletedNCT02191163
Efficacy of Antistax® in Improving Microcirculation of the Skin in the Leg in Patients Suffering From Chronic Venous Insufficiency
A 17 Week, Randomised, Double-blind, Placebo Controlled Cross-over Trial to Evaluate the Efficacy of Antistax® Film Coated Tablets (Extr. Vitis Vinifera Siccum), 360 mg/Day p.o. in Improving Microcirculation of the Skin in the Leg of Male and Female Patients Suffering From Chronic Venous Insufficiency
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 71 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Study to determine the efficacy and safety of Antistax® film coated tablets in improving microcirculation of the skin in the leg of patients with chronic venous insufficiency (CVI)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Antistax® | |
| DRUG | Placebo |
Timeline
- Start date
- 2002-04-01
- Primary completion
- 2002-08-01
- First posted
- 2014-07-16
- Last updated
- 2014-07-16
Source: ClinicalTrials.gov record NCT02191163. Inclusion in this directory is not an endorsement.